Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | -2.48% | -5.77% | +47.92% |
05-08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.92% | 228M | |
+47.03% | 56.87B | |
+37.66% | 39.72B | |
-5.74% | 39.27B | |
-4.42% | 28.73B | |
+13.60% | 26.21B | |
-16.64% | 19.79B | |
+32.71% | 12.28B | |
+27.15% | 12.23B | |
+1.53% | 12.12B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics : Goldman Sachs Initiates Design Therapeutics at Neutral Rating With $28 Price Target